news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

on the evening of september 9, shuangcheng pharmaceutical (002693) announced that on september 6, hainan was hit by the 11th super typhoon "makar" this year. the company's factory is located at no. 16 xingguo road, xiuying district, haikou city, hainan province. it was affected by the superposition of typhoons and heavy rains, and some equipment, facilities and systems in the factory were damaged. after the typhoon disaster, the company immediately launched the disaster emergency plan, organized forces to fully carry out disaster prevention and reduction, and carried out various forms of production self-rescue and corresponding remedial measures to minimize the losses caused by the typhoon disaster to the company's operations.

so far, shuangcheng pharmaceutical’s losses in this typhoon disaster are mainly concentrated in damage to equipment and system engineering. the preliminary estimate of the loss is about 5.2 million yuan, but no casualties have occurred.after the typhoon disaster, the company actively invested in resuming work and production. as of the announcement date, the company's work is progressing in an orderly manner. at present, the company has sufficient inventory, and this disaster will not affect the company's normal supply and sales.

shuangcheng pharmaceutical's main business covers the research and development, production and sales of pharmaceutical injections, solid preparations and apis. the company's main business is the production, sales and research and development of chemically synthesized peptide drugs. the company has formed a complete set of mature technical process systems in the synthesis, purification, analysis, quality assurance, activity determination and preparation technology of chemically synthesized peptide drugs.

judging from the financial data, shuangcheng pharmaceutical's operating performance has not been optimistic in recent years. in 2023, shuangcheng pharmaceutical achieved revenue of 236 million yuan, a year-on-year decrease of 14.13%; the net profit attributable to the parent company was a loss of 50.74 million yuan, compared with 9.012 million yuan in the same period last year.

on august 29, the company disclosed its 2024 semi-annual report showing that in the first half of the year, the company achieved revenue of 94.8926 million yuan, a year-on-year decrease of 31.74%; the net profit attributable to the parent was a loss of 16.9462 million yuan, compared with a profit of 8.7903 million yuan in the same period last year; the non-net profit was a loss of 17.7595 million yuan, compared with a loss of 1.5152 million yuan in the same period last year.

talking about the decline in performance in the first half of the year, shuangcheng pharmaceutical previously stated that with the continued advancement of the national volume-based procurement, provincial centralized procurement or alliance centralized procurement policies, more and more varieties are involved in centralized procurement. the company's main product, somatostatin for injection, has seen a significant drop in price after being included in the national centralized procurement, and some varieties have not been included in the centralized procurement, resulting in a decline in sales; in addition, the company's main product, thymus alpha-sine for injection, was continuously affected by policy adjustments in the same period last year, resulting in a large sales volume, but there was no such factor influencing the sales volume during the reporting period, etc.

it is worth mentioning that recently, shuangcheng pharmaceutical is planning a major asset reorganization and intends to cross-border acquire a semiconductor company. shuangcheng pharmaceutical announced on the evening of august 27 that the company intends to purchase the equity of ningbo aola semiconductor co., ltd. through major asset replacement, issuance of shares and payment of cash, and at the same time intends to issue shares to no more than 35 specific investors to raise supporting funds. aola shares are controlled by the actual controller of the company. the actual controllers of the company, wang chengdong and wang yingpu, control 57.52% of aola shares in total. this transaction constitutes a major asset reorganization.

in addition to shuangcheng pharmaceutical, several hainan listed companies have disclosed announcements about the impact of typhoon disasters.

strait holdings (002320) announced that the company had immediately activated the typhoon emergency plan after the typhoon warning was issued, and took a series of protective measures such as reinforcing and protecting port facilities and transferring ships to anchorages to avoid the typhoon. however, typhoon "makar" with a maximum wind speed of over 17 still caused losses to the company's property.the disaster losses were mainly concentrated in the building components of the xinhai passenger transport integrated hub and some production equipment of xinhai port and xiuying port. the preliminary estimate of the loss was about 90 million yuan, but there were no casualties.most of the damaged assets have been insured, and the insurance company is currently calculating the losses. it is not expected to have a significant impact on the company's financial condition.

haixia co., ltd. said that after the typhoon weakened, the company quickly organized the return of anti-typhoon ships, cleared roadblocks and debris, and repaired production equipment. at 18:00 on september 7, the qiongzhou strait passenger and vehicle transport emergency transportation channel was opened to ensure the rapid crossing of emergency rescue teams, emergency equipment, and daily necessities such as fruits and vegetables. at 13:00 on september 8, the qiongzhou strait passenger and vehicle transport route had started emergency evacuation work.

"at present, the company's production and operation in the disaster-stricken areas have basically returned to normal. repair and maintenance work is being carried out, and various loss reduction measures are being actively taken to strive to minimize the losses. the company continues to take positive actions to ensure the crossing of personnel and materials across the sea, and strives to help the affected people and enterprises resume normal life and production as soon as possible." said strait holdings.

on september 9, according to the wechat public account of hainan coconut island, the coconut island factory and its surrounding areas were affected to varying degrees by the super typhoon "makar". except for the damage to the peripheral areas and some facilities, the core production of the factory was not seriously affected. hainan coconut island has resumed production in an orderly manner on the morning of the 9th to ensure product supply.

hainan coconut island's main business involves health wine, white wine, etc. the company said that it will further replenish materials and ensure supply, sort out the materials needed for resumption of work and production, form a list of materials, and ensure the supply of materials.